systematic review meta-analysis network meta-analysis
 

     

Select             pdf
Filter

  • Group by...
Trial Studied trt Control trt patientstagsROB Trial resultcardiovascular eventsCardiovascular death

diabetes type 2  

ALECARDIO    NCTaleglitazarplacebo -
ALEPREVENT     aleglitazarplaceboLow risk of bias -
ALECARDIO, 2014      NCTaleglitazarplaceboLow risk of bias negative-4%15%



- About - Browse pathology | treatment - Site map - Credits Made with in Lyon - Contact us - Privacy policy - Licence Creative Commons